QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075…
- Recall date
- May 28, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1302-2020
- FDA classification
- Class II
- Brand / firm
- QuVa Pharma, Inc.
- Sold / distributed
- USA Nationwide
Why it was recalled
Subpotent drug - Product did not contain drug.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07
Get recall alerts
Free email alert whenever QuVa Pharma, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: QuVa Pharma, Inc.